GENTEX CORP
For the period ended Dec 31, 2024. Filed Feb 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 25, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 4. Mine Safety Disclosures
Not applicable.
PART II
Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
(a) The Company’s common stock trades on The Nasdaq Global Select Market®under the symbol GNTX. As of January 31, 2025, there were 3,931 record-holders of the Company’s common stock and restricted common stock.
See Item 12 of Part III with respect to "Equity Compensation Plan Information", which is incorporated herein by reference.
Stock Performance Graph: The following graph depicts the cumulative total return on the Company’s common stock compared to the cumulative total return on the Nasdaq Composite Index (all U.S. companies) and the Dow Jones U.S. Auto Parts Index (excluding tire and rubber makers). The graph assumes an investment of $100 on the last trading day of 2019 and reinvestment of dividends in all cases.
In February 2022, the Board approved a continuing resolution to pay a quarterly dividend at a rate of $0.120 per share until the Board takes other action with respect to the payment of dividends. The Company intends to continue to pay a quarterly cash dividend and will consider future dividend rate adjustments based on the Company’s financial condition, profitability, cash flow, liquidity and other relevant business factors.
(b) Not applicable.
(c) The Company has in place and has announced a share repurchase plan. As previously disclosed, the Company may purchase authorized shares of its common stock under the plan based on a number of factors, including: market, economic, and industry conditions; the market price of the Company's common stock; anti- dilutive effect on earnings; available cash; and other factors that the Company deems appropriate. The plan does not have an expiration date, but the Board of Directors reviews such plan periodically.
The following is a summary of share repurchase activity during 2024:
| Issuer Purchase of Equity Securities | |||||
|---|---|---|---|---|---|
| Period · Total Number of Shares Purchased · Average Price Paid Per Share · Total Number of Shares Purchased As Part of a Publicly Announced Plan* · Maximum Number of Shares That May Yet Be Purchased Under the Plan* | |||||
| January 2024 | 90,006 | $33.81 | 90,006 | 15,761,173 | |
| February 2024 | 510,247 | 35.31 | 510,247 | 15,250,926 | |
| March 2024 | 600,650 | 36.59 | 600,650 | 14,650,276 | |
| April 2024 | 60,087 | 34.80 | 60,087 | 14,590,189 | |
| May 2024 | 661,221 | 34.72 | 661,221 | 13,928,968 | |
| June 2024 | 681,359 | 34.12 | 681,359 | 13,247,609 | |
| July 2024 | 150,258 | 31.51 | 150,258 | 13,097,351 | |
| August 2024 | 1,792,167 | 30.01 | 1,792,167 | 11,305,184 | |
| September 2024 | 1,252,390 | 30.20 | 1,252,390 | 10,052,794 | |
| October 2024 | — | — | — | 10,052,794 | |
| November 2024 | 477,641 | 30.59 | 477,641 | 9,575,153 | |
| December 2024 | 125,755 | 30.36 | 125,755 | 9,449,398 | |
| Total | 6,401,781 | 6,401,781 | |||
- See above paragraph with respect to the publicly announced share repurchase plan
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.